logo
How a neurologist faces the disease that is slowly stealing his cognitive powers

How a neurologist faces the disease that is slowly stealing his cognitive powers

It was 2006 when Dr. Daniel Gibbs first noticed he was losing his sense of smell. But it wasn't what he didn't smell that tipped him off that something might be wrong.
It was what he did smell: perfume, mixed with baked bread. "The same thing, every time."
Gibbs, a neurologist in Portland, Oregon, knew this was an olfactory hallucination. And that meant something wasn't working properly in his brain.
"I attributed it to getting older, which is a common cause of decreased ability to smell," he said. But Gibbs was just 57 – not so old that he should be losing his sense of anything. "I also knew losing your sense of smell was an early sign of Parkinson's disease, so I thought it might be that."
It wasn't.
Gibbs was experiencing an early symptom of Alzheimer's disease. But it would be another six years before he knew it. He has since written a book about his experience, which was turned into a documentary. He also keeps a regular blog to help people understand what it's like to live with Alzheimer's. These days, he spends a lot of his time learning and talking about how to slow progression of the disease, something he's been trying to do since he got his diagnosis more than a decade ago.
Gibbs and his wife, Lois Seed, discussed what he's learned about Alzheimer's dementia and how he navigates the condition for " The Experts Say," an American Heart Association News series in which specialists explain how they apply their professional knowledge to their own lives. Their remarks have been edited.
In 2012, Lois was doing a genealogical project, so we did some genetic testing. Mine came back showing I had two copies of APOE4, a gene known to influence the risk of developing Alzheimer's disease, which totally gobsmacked me. Having two copies means it is almost certain to eventually cause Alzheimer's.
I had no measurable cognitive impairment at that time. I was in charge of the neurology resident training program at Oregon Health and Science University in Portland, and I was seeing patients in the clinic, so it was a very busy year for me. Even though it was difficult, I was still able to get all the balls to balance in the air.
What did you do once you knew your genetic risk for Alzheimer's?
The first thing I did was to go to one of my colleagues and have some cognitive testing done. It was essentially normal with the caveat that all of my cognitive domains were in the 90th percentile except verbal memory, which was in the 50th percentile. So there was a strong hint that there was some incipient loss of function of verbal memory.
With that in hand, I went to my department chair and explained the situation. I had no impairment but did not feel it was safe for me to continue to practice. I retired in 2013.
Lois: You also went looking for studies you could join, because it's a big deal to see people before they experience symptoms.
That's right, I went to the University of California in San Francisco, because they have a ton of studies there. The first study I was involved with was a longitudinal neuroimaging study. I had PET scans of abnormal amyloid and PET scans for tau proteins – two protein clusters in the brain that play a role in the development of Alzheimer's disease. And I had cognitive testing.
They loved having me down there because they rarely have people with as early a stage of disease as I showed up with. About a year later, I joined a clinical trial for an anti-amyloid antibody drug that is now approved by the Food and Drug Administration to treat early Alzheimer's disease.
What else did you learn about how to slow progression of the disease?
This is not rocket science. The sort of things that are good preventive behavior for brain disease are also good for preventing heart and vascular disease.
There are evidence-based lifestyle changes that include getting daily aerobic exercise; eating a Mediterranean-style diet, such as the MIND diet; getting mentally stimulating activity; staying socially engaged; getting at least seven hours of sleep nightly; and getting good control of any cerebrovascular risk factors, such as diabetes, high blood pressure, high cholesterol, obesity and smoking.
What's good for the heart is good for the brain!
How do you put this knowledge into practice?
Walking is just built into my day. I do it with my dog, Jack, an 11-year-old English cocker spaniel who is about to age out. He can't keep up with 10,000 steps as easily anymore, so I take some walks by myself. We live in the hills, so I'm getting very good aerobic exercise, short of running.
I used to go to the gym, but that stopped at the start of the COVID pandemic.
I also have a short workout at home. The first thing I do is I use resistance bands, which is a strength exercise. That takes about 15 minutes and then I do tai chi pretty religiously, something I started six months ago. I can clearly see that it helps my balance, but I can't see if it helps my brain, which is continuing to do more poorly.
And thanks to Lois, I've been eating a healthy diet, really forever.
Lois: I didn't have control over those french fries you were eating.
I don't eat red meat anymore. I closely follow the MIND diet, which is essentially the Mediterranean diet with more berries and nuts. It includes a heavy focus on fruits and vegetables, especially green leafy vegetables, beans, nuts, whole grains, seafood, lean poultry and uses olive oil to cook. I'm quite happy with it.
Because I lost my sense of smell, which is totally gone now, I have virtually no taste either. I eat the same thing for lunch and breakfast every day. I enjoy it. I make a sandwich on whole wheat bread that has tuna salad and garbanzo beans, avocado and arugula to get the dark leafy greens. Then some grapes or bananas and half a dark chocolate bar.
Breakfast is homemade granola, and I add cranberries or blueberries. I throw walnuts in as well. Dinner is whatever Lois picks that I can eat.
I stopped drinking alcohol. There's no safe amount of alcohol if you are on this trajectory. So I got rid of it, but I used to love red wine.
Do you know what to expect as the disease progresses?
That's a difficult question to answer. In the old days, when people got a diagnosis of Alzheimer's, they were only living three to five years after that because we made the diagnosis so late. There's less information out there about people who have known they have the disease for a long time and how they will do going forward.
Lois: There's a lot of confusion and misconception because there are different types of dementia. Alzheimer's tends to progress more slowly. The early stage can last 20 years. Here we are 13 years after his diagnosis and Dan's really doing well. I'm a little more of a caregiver than I was a few years ago, but not by much. He dresses himself and monitors medications, and people who talk to him casually wouldn't even know. We've been at that plateau for quite some time.
How would you describe the stage you're at right now?
Right now, I have mild Alzheimer's dementia. To say you have dementia is to say you are having trouble managing your personal affairs. I'm just at a stage now where I can't balance a checkbook. And as things go along, I will have more problems with memory and the ability to recognize people and remember their names.
I've lost my train of thought.
Lois: You were talking about what stage you're at.
When I'm not remembering where I am, then I will have severe dementia.
There are memories I have going back through my whole life. They tend to be events that are emotionally laden.
I'm terrible with names. I know my immediate family members. My neighbors, I forget their names.
Lois is taking over the things I can't manage anymore, like the financial part of our lives, anything that involves planning ahead, scheduling, calendars, remembering all the family stuff, managing the household.
She also goes with me when I have a talk to give.
Lois: He gives talks on Alzheimer's, but almost every time that Dan is getting ready to speak to a group, he gets frustrated and says, "This is the last time I'm doing this," because getting his thoughts together is challenging. He writes out notes. Most of the talks he gives now are screening events for the film with question-and-answer sessions.
It works well if Lois is there to find …
Lois: Words.
That makes it easier.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IVF parents are spending thousands to predict their babies' chances of having Alzheimer's, cancer and heart disease
IVF parents are spending thousands to predict their babies' chances of having Alzheimer's, cancer and heart disease

Yahoo

time2 hours ago

  • Yahoo

IVF parents are spending thousands to predict their babies' chances of having Alzheimer's, cancer and heart disease

Maybe she's born with it, maybe it's … genetic optimization? Prospective parents using in vitro fertilization (IVF) will soon be able to select embryos based on their potential risk for diseases — including illnesses that develop later in life — thanks to a groundbreaking $5,999 service announced this week by a US biotech company. 'Before there's a heartbeat, there's DNA,' Kian Sadeghi, founder and chief executive of Nucleus Genomics, said in a statement. 'One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage.' The popular fertility treatment involves removing eggs from a woman's ovaries and fertilizing them with sperm in a lab. The resulting embryo — which could be frozen or fresh — is placed into the uterus, where it hopefully implants in the uterine wall and sparks a pregnancy. Before implantation, many IVF clinics already screen embryos for genetic abnormalities — such as extra chromosomes or gene mutations — that can lead to failed implantations, miscarriages, birth defects or inherited disorders. But the first-of-its-kind service from Nucleus Genomics takes things a step further. The company just launched Nucleus Embryo, a new software platform that lets potential parents dig deep into the full genetic blueprint of their embryos before choosing which one to implant. The tool lets IVF patients compare the DNA of up to 20 embryos, screening them for more than 900 conditions — including Alzheimer's, Type 2 diabetes, heart disease and several forms of cancer. It doesn't stop there. The program also flags potential mental health conditions like depression and schizophrenia and even ranks cognitive traits like IQ. Parents can also get a look at cosmetic and physical features, from height, baldness and BMI to eye and hair color. The company isn't promising perfection. Instead, the software generates a so-called polygenic risk score that will give parents the probability of how likely it is an embryo might develop certain traits or diseases. Ultimately, it's up to the parents to decide which qualities matter most to them. For those looking to decode the results, genetic counseling sessions are available. 'Lifespan has dramatically increased in the last 150 years,' Sadeghi told the Wall Street Journal. 'DNA testing to predict and reduce chronic disease can make it happen again.' The practice, known as polygenic embryo screening, is already highly controversial in the medical world, according to a report published by Harvard Law School's Petrie-Flom Center. Critics warn that allowing parents to screen embryos for risks like depression or diabetes could deepen stigma and discrimination against people living with those conditions. Meanwhile, disability advocates argue it promotes the harmful idea that disability is something to be fixed, not a natural part of human diversity. And when it comes to choosing embryos for traits like intelligence or athleticism, critics say we're sliding into designer baby territory — a modern form of eugenics that favors the rich, reinforcing social and healthcare inequalities. Still, the public appears open to some aspects of the tech. A 2023 survey found that 77% of Americans support using it to screen embryos for the likelihood of developing certain physical conditions, while 72% back screening for mental health risks. Proponents argue it's no different from vaccination — a preventive tool, not a judgment on those with the condition. But when it comes to non-medical traits, support drops fast: only 36% back screening embryos for behavioral traits and just 30% for physical features like height or eye color.

Your Brain Wrinkles Are Way More Important Than We Ever Realized
Your Brain Wrinkles Are Way More Important Than We Ever Realized

Yahoo

time8 hours ago

  • Yahoo

Your Brain Wrinkles Are Way More Important Than We Ever Realized

The folds and ridges of the human brain are more complex than any other in the animal kingdom, and a new study shows that this complexity may be linked to the brain's level of connectivity and our reasoning abilities. Research led by a team from the University of California, Berkeley (UC Berkeley) looked at the brain shapes and neural activity of 43 young people, and in particular the lateral prefrontal cortex (LPFC) and lateral parietal cortex (LPC) – parts of the brain that handle reasoning and high-level cognition. The grooves and folds on the brain are known as sulci, with the smallest grooves known as tertiary sulci. These are the last to form as the brain grows, and the research team wanted to see how these grooves related to cognition. "The hypothesis is that the formation of sulci leads to shortened distances between connected brain regions, which could lead to increased neural efficiency, and then, in turn, individual differences in improved cognition with translational applications," says neuroscientist Kevin Weiner, from UC Berkeley. The analysis revealed each sulci had its own distinct connectivity pattern, and that the physical structure of some of these grooves was linked to the level of communication between brain areas – and not just areas that were close to each other. It adds to the findings of a 2021 study carried out by some of the same researchers, which found the depth of certain sulci are associated with cognitive reasoning. Now we have more data to help scientists understand why that might be. Between 60 and 70 percent of the brain's cortex (or outer layer) is hidden away inside folds, and these patterns change with age too. Tertiary sulci can vary significantly between individuals as well. "While sulci can change over development, getting deeper or shallower and developing thinner or thicker gray matter – probably in ways that depend on experience – our particular configuration of sulci is a stable individual difference: their size, shape, location and even, for a few sulci, whether they're present or absent," says neuroscientist Silvia Bunge, from UC Berkeley. It's clear from this research that the peaks and valleys of these brain structures are much more important than previously realized. They're not just random folds used to pack brains inside skulls – and may have evolved in certain directions over time. Going forward, the researchers have big plans when it comes to studying brain grooves. Eventually, it's possible that a map of these sulci could help in assessing brain development in children and spotting neurological disorders. There's a lot more work to do before that can happen though, and the researchers are emphasizing that brain fold length and depth are just two of many factors involved when it comes to our cognitive abilities. "Cognitive function depends on variability in a variety of anatomical and functional features," says Bunge. "Importantly, we know that experience, like quality of schooling, plays a powerful role in shaping an individual's cognitive trajectory, and that it is malleable, even in adulthood." The research has been published in the Journal of Neuroscience. Something Strange Happens to Your Eyes When You're Sexually Aroused 2-Year-Old Prodigy Joins 'High IQ' Club Mensa as Youngest Member Ever Traces of Mysterious Ancient Human Population Discovered in Colombia

Charlotte WWII airman accounted for nearly 80 years later
Charlotte WWII airman accounted for nearly 80 years later

Yahoo

time10 hours ago

  • Yahoo

Charlotte WWII airman accounted for nearly 80 years later

U.S. Army Air Forces Tech. Sgt. Clarence E. Gibbs, 21, of Charlotte, has been identified decades after he was killed during a 1944 bombing mission in Germany. ALSO READ: Remains of missing soldiers from World War II uncovered His remains were recovered in a German cemetery and confirmed using DNA and dental analysis. Gibbs will be buried in Clinton, South Carolina, at a later date. In late 1944, Gibbs was assigned to 368th Bombardment Squadron, 306th Bombardment Group, 1st Bombardment Division, 8th Air Force. VIDEO: World War II veteran shares her secret to long life on 100th birthday

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store